Share on LinkedInShare on LinkedIn

ARTICLE · 09 OCTOBER 2024

Major And Minor Cannabinoids: Current Patent Situation

Legislation on cannabis and its derivatives is constantly evolving, and can vary widely from one country to another, including within the European Union.

FranceIntellectual Property

While Germany legalised the use of recreational cannabis in April 2024, France banned the production, sale and use of cannabinoid substances (H4-CBD, H2-CBD, THCP, HHCPO) at the beginning of June 2024 "because of the risks and possible dependence associated with their use", according to the Agence nationale de sécurité du médicament et des produits de santé (French National Agency for the Safety of Medicines and Health Products).

But what do these acronyms mean: H4-CBD, THCP, etc.? Here's a quick look at the "minor cannabinoids" that are of growing interest to manufacturers, as our patent mapping reveals.

As we indicated in our previous article of 17 May 2021, a large number of patent applications relating to cannabis and its uses have already been filed with patent offices, at a rate of around 1,500 to 2,000 publications per year worldwide.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from